Literature DB >> 21972111

Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene.

Kevin M Flanigan1, Diane M Dunn, Andrew von Niederhausern, Payam Soltanzadeh, Michael T Howard, Jacinda B Sampson, Kathryn J Swoboda, Mark B Bromberg, Jerry R Mendell, Laura E Taylor, Christine B Anderson, Alan Pestronk, Julaine M Florence, Anne M Connolly, Katherine D Mathews, Brenda Wong, Richard S Finkel, Carsten G Bonnemann, John W Day, Craig McDonald, Robert B Weiss.   

Abstract

Nonsense mutations are usually predicted to function as null alleles due to premature termination of protein translation. However, nonsense mutations in the DMD gene, encoding the dystrophin protein, have been associated with both the severe Duchenne Muscular Dystrophy (DMD) and milder Becker Muscular Dystrophy (BMD) phenotypes. In a large survey, we identified 243 unique nonsense mutations in the DMD gene, and for 210 of these we could establish definitive phenotypes. We analyzed the reading frame predicted by exons flanking those in which nonsense mutations were found, and present evidence that nonsense mutations resulting in BMD likely do so by inducing exon skipping, confirming that exonic point mutations affecting exon definition have played a significant role in determining phenotype. We present a new model based on the combination of exon definition and intronic splicing regulatory elements for the selective association of BMD nonsense mutations with a subset of DMD exons prone to mutation-induced exon skipping.
© 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21972111      PMCID: PMC3724403          DOI: 10.1002/humu.21426

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  53 in total

1.  A complex intronic splicing enhancer from the c-src pre-mRNA activates inclusion of a heterologous exon.

Authors:  E F Modafferi; D L Black
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

2.  Target RNA motif and target mRNAs of the Quaking STAR protein.

Authors:  André Galarneau; Stéphane Richard
Journal:  Nat Struct Mol Biol       Date:  2005-07-24       Impact factor: 15.369

3.  Alternative splicing of the fibronectin EIIIB exon depends on specific TGCATG repeats.

Authors:  L P Lim; P A Sharp
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

4.  Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort.

Authors:  K M Dent; D M Dunn; A C von Niederhausern; A T Aoyagi; L Kerr; M B Bromberg; K J Hart; T Tuohy; S White; J T den Dunnen; R B Weiss; K M Flanigan
Journal:  Am J Med Genet A       Date:  2005-04-30       Impact factor: 2.802

5.  MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls.

Authors:  B Janssen; C Hartmann; V Scholz; A Jauch; J Zschocke
Journal:  Neurogenetics       Date:  2005-01-18       Impact factor: 2.660

6.  DNA sequence analysis for structure/function and mutation studies in Becker muscular dystrophy.

Authors:  Sa Hamed; Aj Sutherland-Smith; Jrm Gorospe; J Kendrick-Jones; Ep Hoffman
Journal:  Clin Genet       Date:  2005-07       Impact factor: 4.438

7.  Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy.

Authors:  N Shiga; Y Takeshima; H Sakamoto; K Inoue; Y Yokota; M Yokoyama; M Matsuo
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

8.  Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.

Authors:  Andrea Zatkova; Ludwine Messiaen; Ina Vandenbroucke; Rotraud Wieser; Christa Fonatsch; Adrian R Krainer; Katharina Wimmer
Journal:  Hum Mutat       Date:  2004-12       Impact factor: 4.878

9.  Mutation spectrum leading to an attenuated phenotype in dystrophinopathies.

Authors:  Sylvie Tuffery-Giraud; Céline Saquet; Delphine Thorel; Antoine Disset; François Rivier; Sue Malcolm; Mireille Claustres
Journal:  Eur J Hum Genet       Date:  2005-12       Impact factor: 4.246

10.  An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.

Authors:  A Disset; C F Bourgeois; N Benmalek; M Claustres; J Stevenin; Sylvie Tuffery-Giraud
Journal:  Hum Mol Genet       Date:  2006-02-06       Impact factor: 6.150

View more
  46 in total

1.  Novel mutation in spectrin-like repeat 1 of dystrophin central domain causes protein misfolding and mild Becker muscular dystrophy.

Authors:  Gyula Acsadi; Steven A Moore; Angélique Chéron; Olivier Delalande; Lindsey Bennett; William Kupsky; Mohammad El-Baba; Elisabeth Le Rumeur; Jean-François Hubert
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

2.  Evaluation of point mutations in dystrophin gene in Iranian Duchenne and Becker muscular dystrophy patients: introducing three novel variants.

Authors:  Maryam Haghshenas; Mohammad Taghi Akbari; Shohreh Zare Karizi; Faravareh Khordadpoor Deilamani; Shahriar Nafissi; Zivar Salehi
Journal:  J Genet       Date:  2016-06       Impact factor: 1.166

3.  Premature termination codons in the DMD gene cause reduced local mRNA synthesis.

Authors:  Raquel García-Rodríguez; Monika Hiller; Laura Jiménez-Gracia; Zarah van der Pal; Judit Balog; Kevin Adamzek; Annemieke Aartsma-Rus; Pietro Spitali
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-02       Impact factor: 11.205

4.  Highly Efficient CRISPR-Cas9-Based Methods for Generating Deletion Mutations and F0 Embryos that Lack Gene Function in Zebrafish.

Authors:  Kazuyuki Hoshijima; Michael J Jurynec; Dana Klatt Shaw; Ashley M Jacobi; Mark A Behlke; David Jonah Grunwald
Journal:  Dev Cell       Date:  2019-11-07       Impact factor: 12.270

5.  Optimal classification for the diagnosis of duchenne muscular dystrophy images using support vector machines.

Authors:  Ming-Huan Zhang; Jun-Shan Ma; Ying Shen; Ying Chen
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-10-17       Impact factor: 2.924

6.  Conserved regions of the DMD 3' UTR regulate translation and mRNA abundance in cultured myotubes.

Authors:  C Aaron Larsen; Michael T Howard
Journal:  Neuromuscul Disord       Date:  2014-05-22       Impact factor: 4.296

7.  Clinical Utility Gene Card for: Becker muscular dystrophy.

Authors:  David Coote; Mark R Davis; Macarena Cabrera; Merrilee Needham; Nigel G Laing; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-02-21       Impact factor: 4.246

Review 8.  Genetic diagnosis as a tool for personalized treatment of Duchenne muscular dystrophy.

Authors:  Luca Bello; Elena Pegoraro
Journal:  Acta Myol       Date:  2016-12

9.  LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy.

Authors:  Kevin M Flanigan; Ermelinda Ceco; Kay-Marie Lamar; Yuuki Kaminoh; Diane M Dunn; Jerry R Mendell; Wendy M King; Alan Pestronk; Julaine M Florence; Katherine D Mathews; Richard S Finkel; Kathryn J Swoboda; Eduard Gappmaier; Michael T Howard; John W Day; Craig McDonald; Elizabeth M McNally; Robert B Weiss
Journal:  Ann Neurol       Date:  2013-02-20       Impact factor: 10.422

10.  DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.

Authors:  Luca Bello; Lauren P Morgenroth; Heather Gordish-Dressman; Eric P Hoffman; Craig M McDonald; Sebahattin Cirak
Journal:  Neurology       Date:  2016-06-24       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.